|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 以提升语文应用能力为核心的中职语文教学改革实践显示文摘长沙市财经职业中专学校在语文教学改革实践中,根据财经类学生专业发展的需要,以培养学生阅读欣赏、表达交流等语文应用能力为核心,以语文实践活动为载体,推进语文教学内容模块化、组织教学情境化、能力训练项目化、评价方式开放化,为提升学生的综合能力和职业素养奠定了基础。 | Chinese Teaching Research Team(Changsha Financial Secondary Vocational School,Changsha Hu’nan 410000,China) | 2011 | 职业技术教育2011，32，8： | 7 |
| 2 | Determination of Partial Molar Volumes of EPA and DHA Ethyl Esters in Supercritical Carbon Dioxide显示文摘The use of supercritical-fluid chromatography for determining partial molar volumes of ethyl esters of cis-5,8,11,14,17-eicosapentaenoic acid (EPA) and cis -4,7,10,13,16,19- docosa-hexaenoic acid (DHA) in supercritical carbon dioxide is presented and discussed. Partial molar volumes of EPA and DHA esters are obtained from the variation of the retention properties with the density of mobile phase at 313.15 K, 323.15 K, 333.15 K and in the pressure range from 9 MPa to 21 MPa. | Mei HUANG, Xian Da WANG, Ren Tian XIONG, Ping Dong WU, Qi Long REN* National Laboratory of Secondary Resources Chemical Engineering, Zhejiang University, Hangzhou 310027 | 2002 | Chinese Chemical Letters2002，13，1： | 6 |
| 3 | 为每一位学生的终身发展奠基——上海市中小学“二期课改”的探索与实践显示文摘1998年,上海开始启动二期课改。二期课改将“以每一位学生发展为本”作为基本理念,整体设计课程机构,优化课时配比,精选学科内容,引进、改编和开发课程教材,规范和创新课程实施,建设课程资源等。历经10余年的实践,二期课改成果已逐步显现。 | Shanghai Primary and Secondary(Kindergarten) Curriculum Reform Committee | 2011 | 现代基础教育研究2011，1，1： | 2 |
| 4 | Placebo-controlled multicentre randomized trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis显示文摘 | European Study Group on Interferon Beta-1b in Secondary Progressive MS | 1998 | Lancet1998，352，9139： | 1 |
| 5 | A retrospective study of 50 cas- es prior to the calcimimetics era显示文摘 | Conzo G Perna AF Impaet of parathyroideetomy on cardiovascu- lar outcomes and survival in chronic hemodialysis patients with secondary hyperparathyroidism | 2013 | BMC Surgery2013，13，2： | 1 |
| 6 | Biochem显示文摘 | Gupta SK Majundar S Bhattacharya TK Ghosh TC.Studies on the relationships between the synonymous codon usage and protein secondary structural units | | 0，，03： | 1 |
| 7 | Randomized controlled trial of interferon-beta-1a in secondary progressive MS: clinical results显示文摘 | Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-1a in MS (SPECTRIMS) Study Group | 2001 | Neurology2001，56，11： | 1 |
| 8 | The SALT Collaborative Group显示文摘 | Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events | 1991 | Lancet1991，338，： | 1 |
| 9 | EAFT (European Atrial Fibrillation Trial) Study Group显示文摘 | Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke | 1993 | Lancet1993，342，： | 1 |
| 10 | A case of a gi- ant calculus of the submandibular gland显示文摘 | Secondari C Abbatiello A De Stefano C A | 1990 | Minerva Stomatol1990，39，4： | 1 |
| 11 | Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction 显示文摘 | The anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group | 1994 | Lancet1994，343，： | 1 |
| 12 | Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation,a multicenter prospective randomized trial显示文摘 | for Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group | 2000 | Stroke2000，21，： | 1 |
| 13 | TheSALT Collaborative Group显示文摘 | | 1991 | Lancet1991，338，： | 1 |
| 14 | EAFT (European Atrial Fibrillation Trial) Study Group显示文摘 | | 1993 | Lancet1993，342，： | 1 |
| 15 | Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis显示文摘 | European Study Group on Interferon β-1b in Secondary Progressive MS | 1998 | Lancet1998，352，： | 1 |
| 16 | Agency for Health Care Policy and Research and National Heart,Lung,and Blood Institute显示文摘 | Wenger NK Froelicher ES Smith LK et al Cardiac rehabilitation as secondary prevention | | 0，，10： | 1 |
| 17 | Randomized Controlled trial of interferon-beta-la in secondary progressive MS:Clinical results显示文摘 | Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-la in MS(SPECTRIMS) Study Group | 2001 | Neurology2001，56，11： | 1 |
| 18 | Placebo- controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis 显示文摘 | European Study Group on interferon beta-lb in secondary progressive MS | 1998 | Lancet1998，352，9139： | 1 |
| 19 | SUC1 显示文摘 | Tuntiwachwuttikul P Taechowisan T Wanbanjob A et aL Lansai A-D secondary metabolites from Streptomyces sp | 2008 | Tetrahedron2008，64，32： | 1 |
| 20 | Randomized controlled trial of interferon-beta-1a in secondary progressive MS:clinical results 显示文摘 | Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-1a in MS (SPECTRIMS) Study Group | 2001 | Neurology2001，56，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员